Tradestie Institutional Equity Comparison Engine

AXNX vs BSX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BSX Overall Edge

BSX Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Boston Scientific Corp. (BSX) driven by superior Valuation, Growth & Margin, Options & Structure while AXNX counters with relative strength in Momentum & Technical. Fundamentally, AXNX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus BSX at 13.4x Forward P/E and 19.6% operating margin (+1.4% YoY). In options structure, AXNX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BSX sits in CONSOLIDATION (51st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner BSX
AXNX N/M vs BSX 13.4x Fwd P/E
Growth & Margin Winner BSX
Op Margin N/A vs 19.6% ยท YoY N/A vs +1.4%
Momentum & Technical Winner AXNX
1Y +16.9% vs -56.7% ยท 52W Pos 50% vs 4%
Options & Structure Winner BSX
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (51st %ile IV)
AXNX US Equity
AXNX
Institutional Equity
$0.83
-8.28% 1D
Market Cap N/A
1M Return -26.54%
1Y Return +16.92%
Forward P/E N/M
Unified AI Score
52.1 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
BSX NYSE
Boston Scientific Corp.
Surgical & Medical Instruments & Apparatus
$41.98
-2.35% 1D
Market Cap $62.3B
1M Return -8.76%
1Y Return -56.73%
Forward P/E 13.4x
Unified AI Score
60.6 / 100 BUY
Tech 58.0 Fund 59.0 Flow 67.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AXNX +16.92% BSX -56.73% Spread: +19.99 pp (AXNX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AXNX TTM Op. Margin: N/A BSX TTM Op. Margin: 19.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AXNX vs BSX. Trailing 12-month operating profitability (AXNX N/A vs BSX 19.6%) and valuation multiples (AXNX N/M vs BSX 13.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AXNX (1) vs BSX (9)
Institutional Metric AXNX BSX Criterion Row Winner
Market Capitalization Scale N/A $62.3B Larger Scale BSX
Trailing P/E Ratio Valuation N/M 18.1x Lower Multiple BSX
Forward P/E Ratio Valuation N/M 13.4x Lower Multiple BSX
Revenue Growth (YoY) Growth N/A +1.4% Higher Growth BSX
Operating Margin (TTM) Profitability N/A 19.6% Higher Margin BSX
Net Profit Margin Profitability N/A 16.6% Higher Margin BSX
Return on Equity (ROE) Capital Efficiency N/A 14.1% Higher ROE BSX
52-Week Range Position Momentum 50% ($0โ€“$1) 4% ($40โ€“$102) Stronger Trend AXNX
Beta / 30D Volatility Risk Regime N/A 0.34ฮฒ ยท 43% Vol Lower Realized Risk BSX
Unified Institutional Score Composite Signal 52.1 / 100 (HOLD) 60.6 / 100 (BUY) Higher Composite BSX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AXNX vs BSX Buy Guide
AXNX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AXNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BSX CONSOLIDATION
66d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 51st %ile
IV Regime Balanced (25thโ€“60th %ile)
Live BSX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AXNX nor BSX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.